Intech Biopharm Corporation (TPEX:6461)
Taiwan · Delayed Price · Currency is TWD 16.65
+0.10 (0.60%)
Sep 1, 2026, 2:31 PM CST
Intech Biopharm Market Cap
Intech Biopharm has a market cap or net worth of 2.97 billion as of September 8, 2026. Its market cap has decreased by -6.53% in one year.
Market Cap
2.97B
Enterprise Value
4.15B
Revenue
48.55M
Ranking
n/a
PE Ratio
n/a
Stock Price
16.65
ChartMarket Cap Chart
Since July 15, 2014, Intech Biopharm's market cap has decreased from 4.00B to 2.97B, a decrease of -25.85%. That is a compound annual growth rate of -2.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2026 | 2.97B | 2.40% |
| Dec 31, 2025 | 2.90B | -20.37% |
| Dec 31, 2024 | 3.64B | -11.36% |
| Dec 29, 2023 | 4.11B | 5.65% |
| Dec 30, 2022 | 3.89B | 67.22% |
| Dec 30, 2021 | 2.33B | 11.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BioGend Therapeutics | 3.53B |
| SYN-TECH Chem. & Pharm. | 3.36B |
| BRIM Biotechnology | 3.35B |
| OBI Pharma | 3.28B |
| Shine-On BioMedical | 3.20B |
| Apex Biotechnology | 3.17B |
| Sagittarius Life Science | 3.16B |
| Senhwa Biosciences | 3.07B |